TriCert Investment Counsel’s Medtronic MDT Stock Holding History

TriCert Investment Counsel’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.32M	Buy	+93,570	New	+$7.55M	0.68%	47

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

TriCert Investment Counsel's MDT Position: Q2 2026 in Review

TriCert Investment Counsel opened a new position in Medtronic (MDT) in Q2 2026: 93,570 shares worth $7.32M. The stake represents 0.68% of the portfolio and ranks #47 among its holdings.

2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

TriCert Investment Counsel held 93,570 shares of Medtronic worth $7.32M as of Q2 2026.
Medtronic was a new TriCert Investment Counsel position in Q2 2026.
Medtronic made up 0.68% of TriCert Investment Counsel's portfolio in Q2 2026, its #47 holding.
2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TriCert Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.